HealthMore in Health →
CMS Doubles Innovation Team to Drive Down Medicare Drug Costs
The Centers for Medicare and Medicaid Services' innovation arm is more than doubling its staff to develop pilot programs that reduce drug costs across Medicare and Medicaid, signaling aggressive federal action on pharmaceutical pricing.
Key Takeaways
- CMS Innovation Center is more than doubling its dedicated drug pricing team to run new pilot programs
- Expansion targets Medicare and Medicaid prescription costs through multiple concurrent model tests
DE
DT Editorial AI··3 min read·via endpoints.news